Prasterone (GL701) ( DrugBank: Prasterone )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	2

49. 全身性エリテマトーデス

---

臨床試験数 : 993 /  薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00082511 (ClinicalTrials.gov)	July 2003	11/5/2004	GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids	A Multi-Center, Open-Label Study to Assess the Durability and Safety of the Prevention of Bone Loss by Treatment With GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids	Systemic Lupus Erythematosus	Drug: Prasterone (GL701)	Genelabs Technologies	NULL	Completed	18 Years	N/A	Female	114	Phase 3	United States;Mexico
2	NCT00053560 (ClinicalTrials.gov)	December 2002	30/1/2003	To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids	A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids	Lupus	Drug: Prasterone (GL701)	Genelabs Technologies	NULL	Active, not recruiting	18 Years	N/A	Female	155	Phase 3	United States;Mexico